These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26709758)

  • 1. The progress of molecular diagnostics of osteosarcoma.
    Li C; Cong Y; Liu X; Zhou X; Zhou G; Lu M; Shi X; Wu S
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):20-30. PubMed ID: 26709758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes in osteosarcoma.
    Cui J; Wang W; Li Z; Zhang Z; Wu B; Zeng L
    Bull Cancer; 2011 Jul; 98(7):E62-8. PubMed ID: 21708514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions in the treatment of osteosarcoma.
    Bishop MW; Janeway KA; Gorlick R
    Curr Opin Pediatr; 2016 Feb; 28(1):26-33. PubMed ID: 26626558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
    Miao J; Wu S; Peng Z; Tania M; Zhang C
    Tumour Biol; 2013 Aug; 34(4):2093-8. PubMed ID: 23797816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-expression of lncRNA FER1L4 might be a prognostic marker in osteosarcoma.
    Chen ZX; Chen CP; Zhang N; Wang TX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2310-2314. PubMed ID: 29762833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance imaging and radiography for diagnosis of lower limb osteosarcoma: a comparative study].
    Huang H; Chen YP; Cao GH; Lin ZC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1552-4. PubMed ID: 16361162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parosteal osteosarcoma.
    Hang JF; Chen PC
    Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma: Old and New Challenges.
    Yoshida A
    Surg Pathol Clin; 2021 Dec; 14(4):567-583. PubMed ID: 34742481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
    Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
    Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
    Morrow JJ; Khanna C
    Crit Rev Oncog; 2015; 20(3-4):173-97. PubMed ID: 26349415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
    Lamoureux F; Trichet V; Chipoy C; Blanchard F; Gouin F; Redini F
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):169-81. PubMed ID: 17288528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk score model for the prediction of osteosarcoma metastasis.
    Dong S; Huo H; Mao Y; Li X; Dong L
    FEBS Open Bio; 2019 Mar; 9(3):519-526. PubMed ID: 30868060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma: a review of diagnosis, management, and treatment strategies.
    Geller DS; Gorlick R
    Clin Adv Hematol Oncol; 2010 Oct; 8(10):705-18. PubMed ID: 21317869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).
    Yang G; Wu Y; Wan R; Sang H; Liu H; Huang W
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34296296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.
    Ram Kumar RM; Boro A; Fuchs B
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An analysis of genetic transmission in a father and son with osteosarcoma].
    Tokatli F; Alas RC; Altaner S; Pala F; Uygun K; Uzal C; Yalniz E
    Acta Orthop Traumatol Turc; 2006; 40(5):407-10. PubMed ID: 17220652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.